KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Other Accumulated Expenses (2016 - 2026)

HCA Healthcare (HCA) has disclosed Other Accumulated Expenses for 17 consecutive years, with $3.9 billion as the latest value for Q1 2026.

  • For Q1 2026, Other Accumulated Expenses rose 3.48% year-over-year to $3.9 billion; the TTM value through Mar 2026 reached $3.9 billion, up 3.48%, while the annual FY2025 figure was $4.3 billion, 920.76% up from the prior year.
  • Other Accumulated Expenses hit $3.9 billion in Q1 2026 for HCA Healthcare, down from $4.3 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $4.9 billion in Q3 2025 and bottomed at $371.0 million in Q4 2022.
  • Average Other Accumulated Expenses over 5 years is $3.2 billion, with a median of $3.7 billion recorded in 2024.
  • Year-over-year, Other Accumulated Expenses plummeted 88.83% in 2022 and then soared 920.76% in 2025.
  • HCA Healthcare's Other Accumulated Expenses stood at $371.0 million in 2022, then grew by 2.96% to $382.0 million in 2023, then grew by 9.69% to $419.0 million in 2024, then skyrocketed by 920.76% to $4.3 billion in 2025, then fell by 8.86% to $3.9 billion in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $3.9 billion, $4.3 billion, and $4.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.